Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation.

Takeshita S, Fumoto T, Matsuoka K, Park KA, Aburatani H, Kato S, Ito M, Ikeda K.

J Clin Invest. 2013 Sep;123(9):3914-24. doi: 10.1172/JCI69493. Epub 2013 Aug 1.

2.

Cthrc1 is a positive regulator of osteoblastic bone formation.

Kimura H, Kwan KM, Zhang Z, Deng JM, Darnay BG, Behringer RR, Nakamura T, de Crombrugghe B, Akiyama H.

PLoS One. 2008 Sep 9;3(9):e3174. doi: 10.1371/journal.pone.0003174.

3.

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Lüth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, Horne WC, Baron R.

J Clin Invest. 2013 Feb;123(2):666-81. doi: 10.1172/JCI64840. Epub 2013 Jan 16.

4.

High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.

Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P.

Mol Cell Biol. 2002 Sep;22(17):6222-33.

5.

Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.

Weivoda MM, Ruan M, Pederson L, Hachfeld C, Davey RA, Zajac JD, Westendorf JJ, Khosla S, Oursler MJ.

J Bone Miner Res. 2016 Jan;31(1):76-85. doi: 10.1002/jbmr.2586. Epub 2015 Aug 6.

6.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
7.

Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.

Yao Z, Xing L, Qin C, Schwarz EM, Boyce BF.

J Biol Chem. 2008 Apr 11;283(15):9917-24. doi: 10.1074/jbc.M706415200. Epub 2008 Feb 4.

8.

Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.

Sun L, Iqbal J, Dolgilevich S, Yuen T, Wu XB, Moonga BS, Adebanjo OA, Bevis PJ, Lund F, Huang CL, Blair HC, Abe E, Zaidi M.

FASEB J. 2003 Mar;17(3):369-75.

PMID:
12631576
9.

Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.

Jin YR, Stohn JP, Wang Q, Nagano K, Baron R, Bouxsein ML, Rosen CJ, Adarichev VA, Lindner V.

Bone. 2017 Apr;97:153-167. doi: 10.1016/j.bone.2017.01.022. Epub 2017 Jan 21.

PMID:
28115279
10.

Oophorectomy-induced bone loss is attenuated in MAGP1-deficient mice.

Craft CS, Broekelmann TJ, Zou W, Chappel JC, Teitelbaum SL, Mecham RP.

J Cell Biochem. 2012 Jan;113(1):93-9. doi: 10.1002/jcb.23331.

11.

Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Mukherjee A, Rotwein P.

Mol Cell Biol. 2012 Jan;32(2):490-500. doi: 10.1128/MCB.06361-11. Epub 2011 Nov 7.

12.

Osteoclast-derived activity in the coupling of bone formation to resorption.

Martin TJ, Sims NA.

Trends Mol Med. 2005 Feb;11(2):76-81. Review.

PMID:
15694870
13.
14.

Osteoblastic responses to TGF-beta during bone remodeling.

Erlebacher A, Filvaroff EH, Ye JQ, Derynck R.

Mol Biol Cell. 1998 Jul;9(7):1903-18.

15.
16.

Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.

Samee N, Geoffroy V, Marty C, Schiltz C, Vieux-Rochas M, Levi G, de Vernejoul MC.

Am J Pathol. 2008 Sep;173(3):773-80. doi: 10.2353/ajpath.2008.080243. Epub 2008 Jul 31.

17.

Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.

Hoshino A, Iimura T, Ueha S, Hanada S, Maruoka Y, Mayahara M, Suzuki K, Imai T, Ito M, Manome Y, Yasuhara M, Kirino T, Yamaguchi A, Matsushima K, Yamamoto K.

J Biol Chem. 2010 Sep 10;285(37):28826-37. doi: 10.1074/jbc.M109.099424. Epub 2010 Jun 22.

18.

Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions.

Hayashibara T, Hiraga T, Sugita A, Wang L, Hata K, Ooshima T, Yoneda T.

J Bone Miner Res. 2007 Nov;22(11):1743-51.

19.

Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.

Okamoto M, Murai J, Yoshikawa H, Tsumaki N.

J Bone Miner Res. 2006 Jul;21(7):1022-33.

20.

Anti-apoptotic Bcl-2 family member Mcl-1 regulates cell viability and bone-resorbing activity of osteoclasts.

Masuda H, Hirose J, Omata Y, Tokuyama N, Yasui T, Kadono Y, Miyazaki T, Tanaka S.

Bone. 2014 Jan;58:1-10. doi: 10.1016/j.bone.2013.09.020. Epub 2013 Oct 2.

PMID:
24096094

Supplemental Content

Support Center